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The maintenance of meiotic prophase arrest in mouse oocytes within fully grown follicles, prior to the surge of luteinizing hormone (LH) that
triggers meiotic resumption, depends on a high level of cAMP within the oocyte. cAMP is produced within the oocyte, at least in large part, by the
Gs-linked G-protein-coupled receptor, GPR3. Gpr3 is localized in the mouse oocyte but is also present throughout the follicle. To investigate
whether Gpr3 in the follicle cells contributes to the maintenance of meiotic arrest, RNA interference (RNAi) was used to reduce the amount of
Gpr3 RNA within follicle-enclosed oocytes. Follicle-enclosed oocytes injected with small interfering double-stranded RNA (siRNA) targeting
Gpr3, but not control siRNAs, stimulated the resumption of meiosis in the majority of oocytes following a 3-day culture period. Reduction of
RNA was specific for Gpr3 because an unrelated gene was not reduced by microinjection of siRNA. Meiotic resumption was stimulated in
isolated oocytes injected with the same siRNA and cultured for 1 to 2 days, but at a much lower rate than in follicle-enclosed oocytes that could be
cultured for longer. These results demonstrate that GPR3 specifically in the oocyte, rather than in the follicle cells, is responsible for maintenance
of meiotic arrest in mouse oocytes. Furthermore, the method developed here for specifically reducing RNA in follicle-enclosed oocytes, which can
be cultured for a sufficient time to reduce the level of endogenous protein, should be generally useful for targeting a wide range of other proteins
that may be involved in meiotic arrest, the resumption of meiosis, fertilization, or early embryonic development.
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Mammalian oocytes arise and enter meiosis during embryo-
genesis, reaching the dictyate stage of prophase I, at which
point meiosis arrests (Eppig et al., 2004). They remain arrested
in prophase I until a pre-ovulatory surge of luteinizing hormone
(LH) from the pituitary acts on the follicle cells surrounding the
oocyte to stimulate meiotic resumption, as well as cytoplasmic
changes that prepare the oocyte for fertilization (Mehlmann et
al., 1996; Ducibella, 1996, 1998; Eppig et al., 2004). During
the extended period of storage prior to follicular growth, and up
until the surrounding follicle cells begin to develop an antrum,
immature oocytes are held in prophase arrest by inherent
factors, such as subthreshold levels of cell cycle regulatory
proteins (De Vantery et al., 1996, 1997; Kanatsu-Shinohara et0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: lmehlman@neuron.uchc.edu.al., 2000). As follicles begin to form an antrum, the oocyte
acquires the ability to mature into a fertilizable egg and will
mature spontaneously if it is removed from the follicle (Pincus
and Enzmann, 1935; Edwards, 1965; Erickson and Sorensen,
1974; Sorensen and Wassarman, 1976; Mehlmann, 2005).
Thus, after antrum formation, the follicle cells provide a signal
to the oocyte that keeps it arrested at prophase I until the pre-
ovulatory surge of LH.
It is well established that maintenance of meiotic arrest in
meiotically competent oocytes prior to the LH surge depends
on high levels of cAMP within the oocyte (Conti et al., 2002;
Eppig et al., 2004; Mehlmann, 2005). In support of this idea,
maintaining high levels of cAMP within oocytes isolated from
their follicles prevents oocytes from resuming meiosis sponta-
neously (Cho et al., 1974; Schultz et al., 1983; Eppig et al.,
1985), and cAMP levels fall upon oocyte isolation from
follicles (To¨rnell et al., 1990). Cyclic AMP activates protein
kinase A (PKA), which ultimately affects the activity of protein
kinases and phosphatases that favor a net phosphorylation of88 (2005) 397 – 404
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inactive (Duckworth et al., 2002; Lincoln et al., 2002; Eppig et
al., 2004; Mehlmann, 2005). A decrease in the amount of
cAMP following LH stimulation ultimately leads to a net
dephosphorylation of CDK1, thereby activating it and permit-
ting meiotic resumption.
The oocyte produces the cAMP needed for meiotic arrest
through the stimulation of a Gs G protein (Mehlmann et al.,
2002; Kalinowski et al., 2004). Gs stimulates at least one form
of adenylyl cyclase, type 3 (Horner et al., 2003), to produce
cAMP. Gs is stimulated, in turn, by an orphan G-protein-
coupled receptor in the oocyte, GPR3 (Mehlmann et al., 2004;
Freudzon et al., 2005). GPR3 has been characterized in
cultured cells as a constitutive activator of adenylyl cyclase
(Eggerickx et al., 1995; Uhlenbrock et al., 2002), and in mouse
oocytes, it has recently been shown to activate Gs and elevate
cAMP (Freudzon et al., in press). If any of the components of
this signaling pathway are eliminated in the follicle-enclosed
oocyte, it will mature spontaneously (Mehlmann et al., 2002,
2004; Horner et al., 2003; Kalinowski et al., 2004; Ledent et
al., 2005). So far, it is unclear what role the follicle cells play in
the maintenance of meiotic arrest. Follicle cells could produce
a ligand that elevates cAMP production by stimulating GPR3,
and/or inhibit the activity of cAMP phosphodiesterases within
the oocyte, which would help maintain high cAMP levels (see
Mehlmann, 2005).
RNA encoding Gpr3 is expressed primarily in the oocyte
but is also present at lower levels in the surrounding follicle
cells (Mehlmann et al., 2004). Mouse oocytes from animals in
which the Gpr3 gene is knocked out by homologous
recombination undergo LH-independent meiotic resumption
within pre-ovulatory as well as early antral stage follicles
(Mehlmann et al., 2004; Ledent et al., 2005). Although the
ability to maintain meiotic arrest can be rescued in Gpr3/
oocytes by microinjecting follicle-enclosed oocytes with RNA
encoding Gpr3 (Mehlmann et al., 2004), a potential role for
GPR3 in the follicle cells is not completely ruled out. In theory,
any receptor overexpressed in the oocyte that has the ability to
stimulate cAMP production should rescue the ability of the
oocyte to maintain arrest. Because Gpr3 is expressed in the
follicle cells, albeit at low levels, it is possible that the follicle
cells could produce cAMP and provide it to the oocyte through
gap junctions that are present between the oocyte and the
somatic cells (Albertini and Anderson, 1974; Anderson and
Albertini, 1976; Piontkewitz and Dekel, 1993).
The goal of the present study was to resolve the issue of
whether GPR3 within the oocyte or from the surrounding
somatic cells is required for the maintenance of meiotic arrest.
The technique of RNA interference (RNAi), which involves the
introduction of small, interfering double-stranded RNA (siRNA)
into oocytes to trigger sequence-specific degradation of mRNA
(Svoboda et al., 2000, 2001; Wianny and Zernicka-Goetz, 2000;
Xu et al., 2003), was used to reduce levels of mRNA encoding
Gpr3 in follicle-enclosed oocytes. Specific reduction of Gpr3
mRNA from mouse oocytes after 72 h of culture resulted in the
loss of the ability of follicle-enclosed oocytes to maintain
meiotic arrest. In contrast, RNAi was less effective when siRNAwas introduced into isolated oocytes, which cannot be cultured
beyond¨48 h and, therefore, undergo less turnover of RNA and
protein.
These results demonstrate that GPR3 within the oocyte,
rather than in the surrounding follicle cells, is necessary to
maintain meiotic arrest. In addition, the method of injecting
siRNA into follicle-enclosed oocytes that may be cultured for
several days after microinjection should be generally useful in
studying a wide range of proteins involved in meiotic arrest,
the resumption of meiosis, fertilization, or early embryonic
development.Materials and methods
Follicle and oocyte isolation, microinjection, and culture
The mice used for experiments in which follicles were isolated and cultured
were unprimed, 20- to 24-day-old B6SJLF1s (Jackson Laboratories, Bar
Harbor, ME). The medium used for follicle culture was MEMa (#12000-022,
Invitrogen, Carlsbad, CA) supplemented with 25 mM NaHCO3, 75 Ag/ml
penicillin G, 50 Ag/ml streptomycin sulfate, 5 Ag/ml insulin, 5 Ag/ml
transferrin, 5 ng/ml selenium (all from Sigma), 5% fetal bovine serum
(#16000-044, Invitrogen), and 10 ng/ml ovine FSH (provided by A. F. Parlow,
National Hormone and Peptide Program, Torrance, CA), and equilibrated with
5% CO2 and 95% air.
Mice were sacrificed using CO2 asphyxiation. Pre-antral follicles (140–180
Am in diameter) were isolated in 3 ml of MEMa using watchmaker’s forceps
and a 30-gauge syringe needle, as previously described (Mehlmann et al., 2002,
2004). Follicles were transferred to 2 ml MEMa and maintained in an
atmosphere of 5% CO2 and 95% air. Follicle-enclosed oocytes were
microinjected essentially as previously described (Jaffe and Terasaki, 2004;
Kalinowski et al., 2004); the microinjection chamber consisted of two
coverslips separated by a 100-Am spacer formed by a single piece of
doublestick tape, and mounted on a U-shaped plastic slide over a reservoir
of medium. The chamber was observed using a Zeiss Axioskop upright
microscope with a 20 lens (0.5 N.A.). Follicle-enclosed oocytes could readily
be seen inside these chambers, and all microinjected oocytes contained a visible
nucleolus. Four to five follicles were placed in the chamber at one time and
were kept in the chamber at ¨22-C for ¨10–20 min. Following microinjec-
tion, follicles were removed from the chamber and placed in 2 ml medium. An
equal number of uninjected follicles similar in size and appearance to the
injected follicles was put aside into 2 ml of medium, and served as parallel
controls. When all microinjections were completed, injected and uninjected
follicles were placed on Millicell culture plate inserts (PICMORG50, Millipore
Corp., Bedford, MA) in 35-mm Petri dishes, as previously described (Nayudu
and Osborn, 1992). Four to five follicles were placed on each Millicell filter,
and 1.6 ml of medium was placed in the dish underneath the filter. The culture
medium was changed 2 days later by removing 1.2 ml medium and replacing it
with 1.2 ml freshly prepared MEMa containing supplements. During the entire
incubation period, follicles were cultured in a humidified atmosphere contain-
ing 5% CO2 and 95% air.
After a 3-day culture period, oocytes were removed from follicles, the
cumulus cells were removed by repeated pipetting through a small-bore pipet,
and the oocytes were scored for the presence or absence of a nucleus (germinal
vesicle, GV). In some experiments, isolated oocytes were saved and prepared
for RT-PCR by pelleting them briefly at 3000 rpm in 0.6-ml microfuge tubes.
Most of the medium was removed, and the oocytes were quick frozen in
liquid nitrogen and stored at 80-C until use.
For experiments using isolated oocytes, mice were 6- to 12-week-old
B6SJLF1s. The medium used for oocyte collection was MEM with Earle’s
salts, l-glutamine, nonessential amino acids (Sigma), 120 U/ml penicillin G
(potassium salt), 50 Ag/ml streptomycin sulfate, 0.24 mM sodium pyruvate,
0.1% polyvinyl alcohol, and 20 mM HEPES, pH 7.2, and was supplemented
with 250 AM dibutyryl cyclic adenosine monophosphate (dbcAMP) to
prevent spontaneous oocyte maturation (Cho et al., 1974). Mice were
Table 1
Average diameter of follicles grown in culture for at least a 3-day period
Group Diameter (Am)
(number of follicles)
Uninjected 276 T 37 (165)
Low Gpr3 (5 nM) 236 T 50 (26)
High Gpr3 (50 nM) 271 T 35 (73)
mutGpr3 (100 nM) 269 T 38 (42)
GAPDH (100 nM) 292 T 40 (10)
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medium. Full-grown (70–75 Am in diameter) oocytes were collected and
washed through several washes of MEM. Oocytes were microinjected with
siRNA as described previously (Mehlmann et al., 1996). Following
microinjection, oocytes were transferred to MEM in which the HEPES was
replaced with 25 mM NaHCO3, and the dbcAMP was replaced by 4 mM
hypoxanthine. Oocytes were cultured for 26–45 h in an atmosphere
containing 5% CO2 and 95% air, after which they were scored for the
presence or absence of a GV. At the end of the culture period, oocytes were
saved and prepared for RT-PCR by pelleting them gently in small microfuge
tubes. Most of the culture medium was removed, oocytes were quick frozen
in liquid nitrogen and were stored at 80-C until use.
Follicles and isolated oocytes were photographed with a Nikon Coolpix
5000 digital camera coupled to a Zeiss Axiovert 200M microscope, using either
a 20, 0.5 NA or a 40, 0.75 NA lens.
Production of siRNA
Target sequences for the production of siRNA, consisting of two, 21-bp
regions from mouse Gpr3, were selected using the siRNA Target Finder at the
Ambion website (http://www.ambion.com/techlib/misc/siRNA_finder.html).
As a control, one of the Gpr3 targets was mutated in 5 regions (mutGpr3).
For Gpr3, the target sequences were 5V-AAGCUUUGAUUUACUUCUUUG-3V
and 5V-AAUGCUCUCACUUACUACUCA-3V; for mutGpr3, the target se-
quence was 5V-AAUCUGUGCUUGACGUCGUUA-3V. Double-stranded RNA
was produced from the template DNA using the Silencer siRNA Construction
Kit (Ambion), according to the manufacturer’s instructions. The concentration
of each siRNAwas determined by comparing the intensity on a 5% agarose gel,
stained with SYBRGold nucleic acid stain (Molecular Probes Inc., Eugene,
OR), with the intensity of a known amount of siRNA against mouse GAPDH
(Ambion); this GAPDH siRNAwas also used in some experiments as a control.
For all microinjection experiments, 10 pl of siRNA solution was injected
into the oocyte (volume of 200 pl). For Gpr3, both siRNAs were mixed
together and diluted to a stock concentration of ¨1 AM or 0.1 AM, yielding a
final concentration in the oocyte of 50 or 5 nM siRNA, respectively. The
siRNAs against mutGpr3 and GAPDH were diluted to ¨2 AM, for a
cytoplasmic concentration of ¨100 nM. The total number of molecules
injected for all siRNAs ranged from 3104 to 6105.
RT-PCR
cDNA was produced using the Superscript II Reverse Transcriptase kit
(Invitrogen), according to the manufacturer’s instructions and using oligo-dT as
the primer. In most cases, cDNA was produced from isolated oocytes by
resuspending frozen, pelleted oocytes in 10 Al nuclease-free water, without
purifying the RNA. In some cases, RNAwas first purified from isolated oocytes
using TRIzol Reagent (Invitrogen) according to the manufacturer’s instructions.
Both methods yielded similar results. The samples were paired such that in each
experiment, there was an equal number of siRNA-injected and uninjected
oocytes. 9–30 oocytes were processed at a time.
Following reverse transcription, 0.5–2 oocyte equivalents were used for PCR
to amplify Gpr3 and the internal standard ribosomal protein L19 (Rpl19) gene.
Gpr3 and Rpl19 were amplified in the same tube using the following primer
sequences: Gpr3: 5V-TATCCACTCTCCAAGAACCATCTGG-3V and 5V-GGAAT-
TAAGCCCTGGTGGACCTAAC-3V; Rpl19: 5V-GGGAAAAAGAAGGTC-
TGGTTG-3V and 5V-TTCAGCTTGTGGATGTGCTC-3V. The cycling parameters
were an initial denaturation of 2 min, 94-C, followed by 35 cycles of 94-C for
30 s, 55-C for 45 s, 72-C for 45 s, and a final extension at 72-C for 7 min.
PCR products were electrophoresed on 1.5% agarose gels, visualized by
staining the gel with SYBRGold nucleic acid stain, and photographed using
Polaroid film. Photographs were scanned and band intensities quantified using
Scion Image (Scion Corporation, Frederick, MD).
Statistical analysis
InStat software (Graph Pad Software Inc., San Diego, CA) was used to
perform Chi-square analysis or Student’s t tests to determine significantdifferences between different groups. Significance for each experiment is
indicated in the figure legends.
Results
Microinjection of follicle-enclosed oocytes with siRNA
targeting Gpr3 causes meiotic resumption
To reduce Gpr3 mRNA, oocytes within pre-antral follicles
(140–180 Am in diameter) were microinjected with siRNA
targeting mouse Gpr3. Follicles were cultured for 3 days, after
which time oocytes were isolated and were scored for the
presence or absence of a GV, which indicated whether they
were still arrested in prophase I (GV intact) or had resumed
meiosis (GV breakdown; GVBD). During the 3-day culture
period, the follicle diameters increased (Table 1; Fig. 1).
Follicles in which the oocyte had been microinjected grew to
similar sizes as control, uninjected follicles, demonstrating that
the process of microinjection was not damaging to the follicles.
In many cases, follicles developed antral spaces and distinct
mural granulosa and cumulus cell layers (Fig. 1).
67% of follicle-enclosed oocytes microinjected with 50 nM
Gpr3 siRNA underwent GVBD (Fig. 2). In contrast, oocytes
injected with siRNA in which one of the target sequences
against Gpr3 was mutated in several regions (mutGpr3; see
Materials and methods), or with siRNA targeting GAPDH, did
not undergo GVBD. Likewise, uninjected, follicle-enclosed
oocytes isolated on the same day as the injected follicles and
cultured in parallel with injected follicles did not resume
meiosis (Fig. 2). Resumption of meiosis in Gpr3 siRNA-
injected oocytes was dose-dependent, with only 15% of oocytes
injected with 5 nM siRNA undergoing GVBD, compared with
67% of oocytes injected with 50 nM siRNA (Fig. 2). Of the
oocytes that resumed meiosis in response to injection of Gpr3
siRNA, 64% went on to form first polar bodies (see Fig. 2A),
demonstrating that they completed the first meiotic division,
and indicating that oocyte maturation was physiological rather
than a toxic effect of the siRNA. Uninjected oocytes from
control follicles, or follicle-enclosed oocytes injected with 100
nM mutGpr3 or GAPDH siRNA, underwent GVBD much less
frequently, with just 2% of uninjected, 5% of mutGpr3 siRNA,
and 0% of GAPDH siRNA-injected oocytes undergoing
GVBD. These results demonstrate that reduction of Gpr3
RNA within the mouse oocyte causes meiotic resumption and
indicate that GPR3 specifically in the oocyte, rather than in the
follicle cells, is responsible for maintenance of meiotic arrest in
mouse oocytes.
Fig. 1. Follicles containing Gpr3 siRNA-injected oocytes grow in culture. Pre-antral follicles, 140–180 Am in diameter, were dissected from mouse ovaries. Shortly
after isolation, follicle-enclosed oocytes were injected with Gpr3 siRNA. Follicles were subsequently cultured for 3 days on Millicell culture plate inserts. Growth of
a single follicle is shown here shortly following microinjection (Day 0) and after 3 days of culture (Day 3).
Fig. 2. Microinjecting follicle-enclosed oocytes with Gpr3 siRNA stimulates the resumption of meiosis. Follicle-enclosed oocytes were microinjected with siRNA,
follicles were cultured for 3 days, and oocytes were removed and immediately photographed. (A) Oocytes injected with Gpr3 siRNA underwent GVBD and first
polar body formation. Uninjected follicle-enclosed oocytes, or follicle-enclosed oocytes injected with a mutated Gpr3 siRNA sequence (mutGpr3), did not undergo
GVBD during the culture period. (B) Percentage of follicle-enclosed oocytes that underwent resumption of meiosis when injected with different siRNAs. All follicles
were cultured for 3 days following isolation and microinjection, except the follicles injected with siRNA targeting GAPDH, which were cultured for 4 days. Each
experiment was repeated at least 3 separate times. The total number of follicles per condition is indicated above each bar, and significant differences compared to
uninjected control oocytes are indicated above each bar (Chi-square analysis, *P <0.05; **P <0.0001).
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Fig. 4. RNAi is also partially effective in isolated oocytes. (A) Percentage of
isolated oocytes that underwent resumption of meiosis when injected with 50
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reduction of Gpr3 RNA in follicle-enclosed mouse oocytes
The ability of the siRNA targeting Gpr3 to reduce
oocyte Gpr3 mRNA, as well as its specificity, were
assessed by performing RT-PCR on oocytes that were saved
after scoring for GVBD. For RT-PCR analysis, cDNA was
prepared from an equal number of Gpr3 siRNA-injected,
mutGpr3 siRNA-injected, or uninjected oocytes; for each
condition, samples were prepared from at least 3 separate
injection experiments. PCR reactions were run using primers
directed against a combination of Gpr3 and the ribosomal
protein L19 (Rpl19), which should not be decreased by
Gpr3 siRNA, and was therefore used to standardize the
results.
Injection of Gpr3 siRNA reduced the amount of Gpr3
mRNA to ¨10% of that seen in uninjected, control oocytes
(Fig. 3). The amount of Rpl19 mRNA was unaffected. In
addition, mutGpr3 siRNA did not decrease the amount of
Gpr3 mRNA (Fig. 3). These results demonstrate that RNAi
targeting Gpr3 is specific.Fig. 3. (A) Gpr3 siRNA specifically reduces Gpr3 mRNA in follicle-enclosed
oocytes. RT-PCR amplifying Gpr3 and Rpl19 from cDNA prepared from
uninjected oocytes or oocytes which had been injected 3 days earlier with Gpr3
siRNA, or with mutGpr3 siRNA. Only the Gpr3 band was reduced, and only in
oocytes that had been injected with Gpr3 siRNA. (B) Densitometry values
quantifying the reduction of Gpr3 mRNA in oocytes. Data are reported as the
Gpr3:Rpl19 RT-PCR product ratio in siRNA-injected oocytes, as a percentage
of that in uninjected oocytes. MeanTSEM is shown. The statistical significance
of the effect of the siRNA injection was determined using a Student’s t test,
*P < 0.05. Each experiment was performed 3 times, on 3 different batches
of cDNA per group.
nM Gpr3 siRNA. Oocytes were cultured for 1–2 days following microinjec-
tion of siRNA. The total number of oocytes from 3 separate experiments is
indicated above the bars, and ** indicates significance between the two groups
(P < 0.0001). (B) Specific reduction of Gpr3 RNA in oocytes microinjected
with siRNA targeting GPR3. RT-PCR amplifying Gpr3 and Rpl19 from cDNA
prepared from uninjected or Gpr3 siRNA-injected, isolated oocytes following
45 h of culture. The reduction in Gpr3 RNA is less than in follicle-enclosed
oocytes cultured for 72 h.RNAi causes meiotic resumption and reduces Gpr3 mRNA in
isolated oocytes but to a lesser extent than in follicle-enclosed
oocytes
RNAi has been used effectively in isolated mouse oocytes to
prevent maturation-associated increases in proteins that are
normally produced as a result of recruitment of maternal
mRNAs (Svoboda et al., 2000; Xu et al., 2003; Anger et al.,
2005). However, oocytes can only be cultured for ¨2 days
following isolation, after which time they will no longer mature
in vitro (unpublished results). Therefore, in some cases, it may
be impossible to sufficiently reduce the amount of the
corresponding proteins in isolated oocytes, particularly if the
proteins have low turnover rates. To compare the effectiveness
of RNAi in follicle-enclosed vs. isolated oocytes, isolated
oocytes were microinjected with 50 nM Gpr3 siRNA and were
cultured in the presence of 4 mM hypoxanthine to maintain
meiotic arrest (Mehlmann et al., 2002). Oocytes were cultured
for 26–45 h and then were scored for the presence or absence
of a GV. GVBD occurred in isolated oocytes, though at a much
lower rate than in follicle-enclosed oocytes cultured for 72
h (16% GVBD in isolated oocytes, compared with 67% GVBD
in follicle-enclosed oocytes; Fig. 4A).
The lower percentage of isolated oocytes that resumed
meiosis probably resulted because the oocytes were not
cultured long enough to reduce the amount of pre-existing
GPR3 protein. Indeed, RT-PCR analysis showed that RNAi-
mediated reduction of Gpr3 RNA in isolated oocytes that were
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enclosed oocytes that were cultured for 3 days (59 T 13%
(mean T SEM, n = 3) for isolated oocytes, vs. 88 T 3% (n = 4)
for follicle-enclosed oocytes). These results show that RNAi is
more effective in reducing RNA (and therefore protein) in
follicle-enclosed oocytes than in isolated oocytes, due to the
limited period for which isolated oocytes can be cultured
lacking granulosa cell support.
Discussion
Recent characterization of knockout mice has demonstrated
a critical role for the G-protein-coupled receptor, GPR3, in the
maintenance of meiotic arrest (Mehlmann et al., 2004; Ledent
et al., 2005). However, while Gpr3 RNA is primarily localized
in the oocyte, it is also present in lower quantities in the
surrounding follicle cells (Mehlmann et al., 2004), leaving
open the question of whether GPR3 in the follicle cells is
essential for the maintenance of meiotic arrest, perhaps by
producing cAMP that enters the oocyte via gap junctions
(Anderson and Albertini, 1976; Bornslaeger and Schultz, 1985;
Piontkewitz and Dekel, 1993; Webb et al., 2002; Eppig et al.,
2004). Here, Gpr3 was reduced specifically within the oocyte
by microinjecting follicle-enclosed oocytes with siRNA target-
ing Gpr3. Within 3 days of culture following microinjection,
oocytes injected with Gpr3 siRNA, but not with control
siRNA, lost their ability to maintain meiotic arrest. The ¨70%
GVBD observed following siRNA injection into oocytes is
very close to the ¨80–90% seen with deletion of Gpr3 RNA
from both oocyte and follicle cells in Gpr3 knockout mice
(Mehlmann et al., 2004). Therefore, the phenotype of the
knockout mice can be mimicked by specific reduction of Gpr3
in the oocyte, demonstrating that GPR3 specifically within the
oocyte is necessary to maintain meiotic arrest prior to the LH
surge.
GVBD was also observed in a small percentage of isolated
oocytes injected with siRNA targeting Gpr3. Because these
oocytes had no surrounding follicle cells but were maintained in
meiotic arrest by hypoxanthine, this result further supports the
hypothesis that elimination of GPR3 itself is sufficient to trigger
the resumption of meiosis. Gpr3 mRNA was less effectively
reduced in isolated oocytes cultured for 1–2 days following
injection of the same amount of siRNA than in follicle-enclosed
oocytes that were cultured for 3 days (compare Figs. 3A and 4B).
This is likely due to the longer period afforded by growing
oocytes within their follicles that provides more time for the
reduced mRNA levels to result in a reduction in GPR3 protein.
Native levels of G-protein-coupled receptors are generally
difficult to detect using antibodies because the amounts of these
proteins in cells are low (Daly and McGrath, 2003); we have
been unable to detect specific labeling of GPR3 using
commercially available antibodies used by others (Ledent et
al., 2005), or with 3 custom synthesized antibodies (L.M.
Mehlmann, L.A. Jaffe, S. Tanaka, and Y. Saeki, unpublished
results). For this reason, protein levels of GPR3 could not be
directly measured in this study. However, the resumption of
meiosis that was observed in siRNA-injected oocytes is anindirect indicator of a physiologically significant decrease in
GPR3 protein leading to a decrease in cAMP.
In isolated mouse oocytes, RNAi has previously been used
effectively to prevent the expression of proteins that accumu-
late during oocyte maturation (Svoboda et al., 2000, 2001;
Wianny and Zernicka-Goetz, 2000; Xu et al., 2003; Anger et
al., 2005). However, the technique is limited using isolated
oocytes because they can only be cultured for a relatively short
period that may not be sufficient to reduce the amount of pre-
existing proteins to a level needed to observe a phenotype,
particularly if the proteins in question are stable and/or are
present before and during oocyte maturation. Indeed, in one
study utilizing RNAi to prevent the oocyte maturation-
associated increase in the IP3 receptor in isolated oocytes, the
increase in receptor protein was prevented, but the level of
existing protein did not change during the 14- to 16-h culture
period (Xu et al., 2003).
To combat this problem, transgenic mice have been produced
in which the synthesis of siRNA is driven by an oocyte-specific
promoter, such that specific reduction of mRNA can begin
earlier in oogenesis (Stein et al., 2003; Fedoriw et al., 2004; Yu et
al., 2004). However, this method results in different degrees of
mRNA targeting, yielding variable amounts of protein reduction
(Stein et al., 2003; Fedoriw et al., 2004; Yu et al., 2004). Oocyte-
specific, conditional knockouts have been shown to effectively
eliminate oocyte proteins (He et al., 2003), but this method is
expensive and time consuming. In contrast, the method
presented here utilizes an effective, alternative approach that
has several advantages. The ability to introduce a known amount
of siRNA directly into oocytes is an advantage over transgenic
RNAi approaches in which the amount of dsRNA is not known.
The ability to microinject oocytes within pre-antral follicles and
culture the follicles for several days following microinjection
allows for a more complete reduction of the targeted RNA and
protein. Furthermore, with this method, the oocytes are cultured
within follicles that more closely approximate their natural
environment, thereby obviating the need for a culture system that
maintains high levels of cAMP using artificial means. In
addition, the method is relatively easy, requires only a few
animals, and results are obtained within a matter of days.
The method used here employed synthetically produced
dsRNAs 21 bp in length. In contrast, in other studies, longer
dsRNAs were used to effectively reduce mRNA levels in
oocytes (Svoboda et al., 2000, 2001; Wianny and Zernicka-
Goetz, 2000; Xu et al., 2003; Anger et al., 2005). Such long,
dsRNAs are cleaved within the oocyte to yield fragments 21–23
nucleotides in length (Zamore et al., 2000). Bothmethods appear
to be effective in reducing specific mRNAs within mouse
oocytes.
The results presented here demonstrate that reduction of
GPR3 specifically in the follicle-enclosed mouse oocyte
causes meiotic resumption. Combined with our previous
study showing that expression of GPR3 specifically into
oocytes within follicles of Gpr3 knockout mice can rescue the
ability of the Gpr3/ oocytes to maintain meiotic arrest
(Mehlmann et al., 2004), they provide strong support for the
hypothesis that the oocyte is primarily responsible for
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that the follicle cells also contribute cAMP to the oocyte, but
clearly, the amount of cAMP produced by the follicle cells is
insufficient to maintain meiotic arrest. In addition, the ability
to inject substances into follicle-enclosed oocytes and grow
follicles for several days in culture establishes a method that
could be generally useful for targeting a wide variety of
proteins specifically within the oocyte. Follicles grown in
culture can respond to LH, and matured eggs obtained from
them are fertilizable (Eppig, 1991; Rose et al., 1999). Thus,
this method of microinjection of follicle-enclosed oocytes,
followed by in vitro follicle culture, could be used to examine
a variety of questions pertaining to meiotic maturation,
fertilization, and early development.
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